SCHEMBL29854466

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.79

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	12/20	0.79

▸	NPY1R	P25929	9/20	0.79

▸	NPY4R	P50391	8/20	0.79

▸	NPY5R	Q15761	8/20	0.79

▸	TFPI	P10646	2/20	0.62

▸	NMUR2	Q9GZQ4	3/20	0.61

▸	NMUR1	Q9HB89	3/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29527200	0.99	NPY2R (0.79)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL29854495	0.93	NPY2R (0.72)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL29854567	0.91	NPY2R (0.68)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL29854478	0.91	NPY2R (0.70)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL29854544	0.90	NPY2R (0.67)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL30495647	0.90	NPY2R (0.77)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL13248707	0.88	NPY2R (0.80)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL31651397	0.88	NPY2R (0.71)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL30607435	0.87	NPY2R (0.76)	NPY2RNPY1RNPY4RNPY5RTFPI
SCHEMBL30262086	0.87	NPY2R (0.69)	NPY2RNPY1RNPY4RNPY5RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220257719-A1	APPETITE SUPPRESSING COMPOUNDS	IP2IPO INNOVATIONS LIMITED (GB)	2022-08-18	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220257719-A1	APPETITE SUPPRESSING COMPOUNDS	GIPR, GPR119, IAPP	NPY2R 8/4885NPY1R 7/4885NPY4R 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.